Oruka Therapeutics, Inc.

ORKA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$94.79-1.78%

2026-08-03

Financials

Valuation Metrics

Oruka Therapeutics, Inc.'s Market Cap is $5.72B. At end of 2025 it was $1.65B. Ranked #1301 of 3,112 in US market (top 42%), #438 of 1,445 on NASDAQ (top 30%), #73 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 27%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$5.72B	US#1,301/3,112 Sec#73/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-116M	US—/3,112 Sec—/269
Total Assets	$504M	US#2,740/3,112 Sec#157/269
Net Assets	$487M	US#2,276/3,112 Sec#116/269
Value
P/B	11.75x	US#2,667/3,112 Sec#211/269
FCF Yield	-1.60%	US—/3,112 Sec—/269
Profitability
ROE	-23.89%	US#2,567/3,112 Sec#113/269
ROA	-23.04%	US#2,809/3,112 Sec#135/269
Financial Health
Debt Ratio	3.65%	US#31/3,112 Sec#8/269
Total Debt	$2M	US#2,909/3,112 Sec#236/269
FCF	$-91M	US#2,573/3,112 Sec#145/269
Cash	$50M	US#2,591/3,112 Sec#229/269
Current Ratio	23.76x	US#106/3,112 Sec#20/269
Performance
1Y Return	596.99%	US#10/3,112 Sec#4/269
1M Return	11.24%	US#459/3,112 Sec#20/269
From 52W High	-4.25%	US#478/3,112 Sec#18/269
1Y MDD	-27.99%	US#1,243/3,112 Sec#77/269
Trading
Volume	792,809 shares	US#1,695/3,112 Sec#161/269
Trading Value	$75M	US#1,088/3,112 Sec#65/269
Per Share
EPS	$-1.94	US—/3,112 Sec—/269
BPS	$8.67	US#1,877/3,112 Sec#74/269